HCA Healthcare (NYSE:HCA) Price Target Raised to $520.00

HCA Healthcare (NYSE:HCA) had its target price lifted by Truist Financial from $495.00 to $520.00 in a research note published on Monday morning,MarketScreener reports. Truist Financial currently has a buy rating on the stock.

HCA has been the topic of several other reports. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Stephens lifted their target price on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Wells Fargo & Company raised their price target on HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a research report on Thursday, November 13th. Oppenheimer increased their target price on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. Finally, TD Cowen upped their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fourteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $485.95.

HCA Healthcare Stock Down 2.8%

HCA Healthcare stock opened at $470.23 on Monday. HCA Healthcare has a 12-month low of $295.00 and a 12-month high of $520.00. The business’s 50-day simple moving average is $479.37 and its 200 day simple moving average is $426.03. The stock has a market cap of $107.30 billion, a price-to-earnings ratio of 18.18, a P/E/G ratio of 1.33 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same period last year, the firm earned $4.90 earnings per share. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts expect that HCA Healthcare will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were given a $0.72 dividend. The ex-dividend date of this dividend was Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of HCA. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the 3rd quarter valued at about $26,000. Ameriflex Group Inc. acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $27,000. Chung Wu Investment Group LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $27,000. Clearstead Trust LLC boosted its position in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Finally, Holos Integrated Wealth LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth about $29,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.